Next Article in Journal
Interaction and Compatibility Studies in the Development of Olmesartan Medoxomil and Hydrochlorothiazide Formulations under a Real Manufacturing Process
Next Article in Special Issue
Intranasal Immunization with Zika Virus Envelope Domain III-Flagellin Fusion Protein Elicits Systemic and Mucosal Immune Responses and Protection against Subcutaneous and Intravaginal Virus Challenges
Previous Article in Journal
A Nanosized Codelivery System Based on Intracellular Stimuli-Triggered Dual-Drug Release for Multilevel Chemotherapy Amplification in Drug-Resistant Breast Cancer
Previous Article in Special Issue
A Polylactide-Based Micellar Adjuvant Improves the Intensity and Quality of Immune Response
 
 
Due to scheduled maintenance work on our database systems, there may be short service disruptions on this website between 10:00 and 11:00 CEST on June 14th.
Review

Article Versions Notes

Pharmaceutics 2022, 14(2), 423; https://doi.org/10.3390/pharmaceutics14020423
Action Date Notes Link
article xml file uploaded 16 February 2022 08:52 CET Original file -
article xml uploaded. 16 February 2022 08:52 CET Update -
article pdf uploaded. 16 February 2022 08:52 CET Version of Record https://www.mdpi.com/1999-4923/14/2/423/pdf-vor
article html file updated 16 February 2022 08:53 CET Original file -
article xml file uploaded 17 February 2022 08:12 CET Update -
article xml uploaded. 17 February 2022 08:12 CET Update https://www.mdpi.com/1999-4923/14/2/423/xml
article pdf uploaded. 17 February 2022 08:12 CET Updated version of record https://www.mdpi.com/1999-4923/14/2/423/pdf
article html file updated 17 February 2022 08:13 CET Update -
article html file updated 31 July 2022 19:21 CEST Update https://www.mdpi.com/1999-4923/14/2/423/html
Back to TopTop